Medical information and drug safety
For Medical Information enquiries, please contact email@example.com
All pharmacologically effective drugs have benefits and risks. The risk may be insignificant or may be acceptable in relation to the drug's therapeutic action. Continuous monitoring of the safety of a drug throughout the duration of its use helps to ensure that its risks and benefits remain acceptable. hameln is committed to protecting the safety of patients who receive our products.
Adverse events should be reported to hameln on +44 (0)1452 621661 or by email firstname.lastname@example.org
Reporting forms and information can also be found on the MHRA website www.mhra.gov.uk/yellowcard